abs425.txt	background		epidemiologic	evidence	for	a	serum	cholesterol-prostate	cancer	linkis	mixed	prostate-specific	antigen	(psa)	is	positively	correlated	withcholesterol	potentially	increasing	psa-driven	biopsy	recommendations	in	men	withhigh	cholesterol	though	compliance	may	be	lower	with	comorbidconditions	these	potential	biases	affect	rates	andsubsequent	prostate	detection	high	ourobjective	was	to	test	the	association	between	and	prostatecancer	risk	receiving	psa	independent	study-mandated	biopsies	methods	we	conducted	post	hoc	analysis	of	data	from	4974	non-statin	users	inreduce	randomized	trial	elevated	negative	baselinebiopsy	underwent	2-	4-year	trial-mandated	associations	baseline	levels	total	low-densitylipoprotein	(ldl)	high-density	lipoprotein	(hdl)	overall	by	gleason	grade	(<7	vs	â‰¥7)	were	examined	using	multivariablelogistic	regression	results	associated	an	increased	ofhigh-grade	diagnosis	(or	per	10	mg/dl	1	05	95%	ci	00-1	09	p	=	0	048)	but	unrelated	either	or	low-grade	(p-values	>0	185)	there	no	ldl	andoverall	low-	high-grade	137)	contrast	hdl	both	per10	08	01-1	16	033)	(orper	14	28	034)	conclusions	reduce	where	all	received	trial-mandatedbiopsies	thus	ensuring	complete	ascertainment	serumcholesterol	high-gradeprostate	supporting	link
